Dialysis Equipment Market (2026 - 2035)

Dialysis Equipment Market Summary

The global dialysis equipment market size was valued at USD 8.7 billion in 2025 and is projected to grow from USD 9.3 billion in 2026 to USD 17.3 billion by 2035, at a CAGR of 7.1% from 2026 to 2035. North America dominated the market, accounting for the largest revenue share in 2025. The industry is witnessing steady growth, driven by the rising global prevalence of chronic kidney disease (CKD), end-stage renal disease (ESRD), diabetes, and hypertension, which remain the leading causes of kidney failure.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The growing aging population, rising prevalence of diabetes, hypertension, and other chronic conditions associated with kidney disease, and an increase in the number of patients requiring kidney replacement therapy are supporting demand for advanced dialysis equipment. Moreover, improved healthcare infrastructure and accessibility to dialysis procedures, especially in developing countries, are contributing to market growth. The World Health Organization (WHO) identifies an aging population, diabetes, and hypertension as major factors behind the rising global burden of kidney disease, while highlighting persistent inequities in access to dialysis and other kidney replacement therapies.

Technological advancements in dialysis equipment have transformed patient care by improving treatment efficiency, safety, and convenience. Manufacturers are introducing next-generation hemodialysis machines, automated peritoneal dialysis systems, and digital monitoring solutions that enable more personalized treatment and remote patient management. Increasing adoption of home dialysis equipment, supported by portable devices, telehealth integration, and connected healthcare technologies, is further expanding treatment options and potentially reducing the burden on healthcare facilities. For example, the U.S. FDA cleared Quanta Dialysis Technologies’ SC+ Hemodialysis Device for home use in November 2024, highlighting the continued development of compact home hemodialysis technologies.

Growing investments by healthcare providers and medical device companies in research and development of their products and manufacturing capabilities are further supporting the market growth. Strategic collaborations, regulatory approvals, and the continuous launch of products are expanding the availability of technologically advanced dialysis systems that offer improved operational efficiency and enhanced treatment quality. Recent regulatory activity also reflects ongoing product development; for example, the FDA granted 510(k) clearance to Nikkiso’s DBB-06 PRO Hemodialysis Delivery System in May 2025. In addition, supportive government policies aimed at improving access to renal health care and increasing reimbursement rates for dialysis treatments are expected to further drive demand.

Analyst Perspective

The dialysis equipment market is driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), rising cases of diabetes and hypertension, and an increasing geriatric population globally. The growing demand for renal replacement therapy, along with improvements in healthcare infrastructure and access to dialysis services, continues to support market growth. Moreover, rapid developments in the technology used in hemodialysis and peritoneal dialysis machines, increased use of home-based dialysis therapies, the incorporation of digital health and remote patient monitoring technologies, and positive government policies concerning the management of kidney disease present significant opportunities for market participants during the forecast period. In addition, increased investments in portable dialysis systems, AI-enabled monitoring systems, and connected care platforms are expected to create significant growth opportunities.

Product Insights

The hemodialysis equipment segment dominated the dialysis equipment market and accounted for the largest revenue share in 2025. It is attributed to the extensive use of in-center hemodialysis for patients with end-stage renal disease (ESRD), owing to the high efficiency of this treatment and the existing healthcare infrastructure. The increasing prevalence of chronic kidney disease (CKD), the growing demand for advanced dialysis machines, and ongoing innovations in hemodialysis equipment are major factors driving the growth of this segment. The introduction of new-generation hemodialysis machines with enhanced features, such as automation and safety, is expected to contribute to the segment growth.

The peritoneal dialysis equipment segment is expected to register a notable CAGR during the forecast period. The rising preference for home-based dialysis, the increasing awareness regarding the patient-centered approach, and the growing demand for flexible treatment options are contributing to the adoption of peritoneal dialysis systems. Increasing innovation in automated peritoneal dialysis and remote patient monitoring devices is supporting segment growth. Moreover, favorable reimbursement policies, supportive government policies for home dialysis, and increased investment in peritoneal dialysis technologies by leading companies are expected to drive segment growth during the forecast period. For instance, in June 2026, Fresenius Medical Care introduced Kinexus, a global digital platform to support home dialysis programs. The platform connects remote therapy monitoring and operational workflows for both peritoneal dialysis and home hemodialysis, helping care teams manage home treatments through a unified system.

End Use Insights

The dialysis centers segment dominated the dialysis equipment market, accounting for the largest revenue share in 2025. Specialized dialysis centers continue to dominate owing to their specialized infrastructure, skilled professionals with expertise in nephrology, and provision of complete renal replacement therapy to numerous patients. The increasing prevalence of chronic kidney disease, the expansion of independent dialysis center networks, and investments in the latest dialysis equipment are contributing to the segment's growth. In addition, the provision of specialized clinical services, patient monitoring, and the presence of positive reimbursement policies have reinforced the dominance of dialysis centers in delivering routine dialysis treatment.

The home care settings segment is expected to exhibit the fastest growth rate during the forecast period. Increasing emphasis on patient convenience, rising adoption of home hemodialysis and peritoneal dialysis, and the advent of portable dialysis equipment are expected to contribute to the growth of this segment. Home care provides flexibility, a higher quality of life, decreased travel burden, and patient independence. In addition, the introduction of telehealth technology, patient monitoring, and digital connectivity in home dialysis equipment improves patient care and patient compliance. Positive healthcare policies and acceptance of home dialysis by physicians are set to boost market growth. For instance, in April 2024, Outset Medical and U.S. Renal Care announced a multi-year agreement to accelerate the adoption of home hemodialysis using the Tablo Hemodialysis System. The collaboration aimed to expand patient access to home dialysis by simplifying treatment delivery through a compact, integrated dialysis system with digital capabilities.

Regional Insights

The North America dialysis equipment market dominated the global industry and accounted for the largest revenue share in 2025, supported by higher rates of chronic kidney disease and end-stage renal disease, advanced healthcare infrastructure, reimbursement policies, and the availability of technologically advanced dialysis equipment. The growth in the region is attributed to the presence of leading manufacturers of dialysis equipment, dialysis centers, and product innovations. Moreover, growing use of home dialysis equipment, related regulations, and increasing investments in renal care are also among the key factors favoring the growth of the dialysis equipment industry in North America. For instance, in February 2024, Fresenius Medical Care announced its U.S. FDA 510(k) clearance of 5008X Hemodialysis System, enabling the company to introduce high-volume hemodiafiltration (HDF) therapy in the U.S. market. The launch reflects continued investment in next-generation dialysis solutions, strengthening the region’s position as a major market for advanced dialysis technologies.

Asia Pacific Dialysis Equipment Market Trends

The dialysis equipment market in the Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period. Growth in the prevalence of diabetes and hypertension, incidences of chronic kidney disease, growing healthcare infrastructure, and renal replacement therapies are the main drivers of the regional growth. Countries such as China, India, Japan, and South Korea are seeing significant investment in dialysis centers and advanced medical equipment. In addition, increasing awareness of the early management of kidney diseases offers numerous opportunities for dialysis equipment manufacturers in the coming years. For instance, in March 2025, Queensland Health opened a new satellite renal dialysis unit at Capricorn Coast Hospital in Australia following a USD 10.37 million investment to improve access to dialysis services. The new facility expanded regional dialysis capacity and strengthened the renal care infrastructure, reflecting broader healthcare investments across the Asia-Pacific region aimed at improving access to dialysis treatment.

Key Dialysis Equipment Company Insights

The dialysis equipment market is highly competitive, with leading medical device and kidney care companies focusing on product innovation, technology development, strategic partnerships, and geographic expansion. Product launches, regulatory clearances, collaborations, acquisitions, and the expansion of manufacturing and distribution capabilities are key strategies companies adopt to strengthen their market position and broaden their reach.

Key Dialysis Equipment Companies

The following key companies have been profiled for this study on the dialysis equipment market:

• Fresenius Medical Care AG

• Vantive

• B. Braun SE

• Nipro Europe Group Companies

• Nikkiso Co., Ltd.

• Outset Medical, Inc.

• Mozarc Medical (Medtronic)

• TORAY MEDICAL CO., LTD.

• Rockwell Medical, Inc.

• Quanta Dialysis Technologies Inc.

Recent Developments

• In December 2025, Nikkiso launched DBB-06 PRO hemodialysis machine for the U.S. market, introducing a next-generation hemodialysis system featuring full assist functionality, simplified operation, and enhanced monitoring capabilities.

• In February 2025, Vantive began operating as a standalone kidney-care company after Carlyle completed its acquisition of Baxter's Kidney Care business. The business includes products for peritoneal dialysis, hemodialysis, and continuous renal replacement therapy. Vantive operates as an independent company focused on kidney and vital-organ therapies.

Global Dialysis Equipment Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2035. For this study, Grand View Research has segmented the global dialysis equipment market report based on product, end use, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2035)

  • Hemodialysis Equipment

  • Peritoneal Dialysis Equipment

  • Continuous Renal Replacement Therapy (CRRT) Systems

  • Water Treatment Systems

  • Others

• End Use Outlook (Revenue, USD Billion, 2021 - 2035)

  • Dialysis Centers

  • Hospitals

  • Home Care Settings

• Regional Outlook (Revenue, USD Billion, 2021 - 2035)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE